Palio Announces Partnership with Zemoga

Launches Blog: Pixels and Pills SARATOGA SPRINGS, NY, AUGUST 21, 2009—Palio, an inVentiv Health (NASDAQ: VTIV) company, has formalized a partnership with Zemoga, a full-service interactive agency, to tackle the changing nature of digital media...

ARIAD And Its Co-Plaintiffs Announce That the Court of Appeals Granted Their Petition for Rehearing En Banc In the Lilly NF-kB Patent Lawsuit

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 24, 2009 - ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and its co-plaintiffs today announced that the U.S. Court of Appeals for the Federal Circuit (the “Federal...

MedWatch - Orlistat (marketed as Alli and Xenical): FDA reviewing reports of serious liver injury, including liver failure

ROCKVILLE, Md., Aug. 24, 2009--FDA notified healthcare professionals and patients that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat. Orlistat is marketed in the United...

MedWatch - Intelence (etravirine):Reports of severe, potentially life-threatening and fatal skin reactions

ROCKVILLE, Md., Aug. 27, 2009--Tibotec Therapeutics and FDA notified healthcare professionals of revisions to the WARNINGS AND PRECAUTIONS section of the prescribing information for Intelence (etravirine). There have been postmarketing reports of...

Ligand to Acquire Neurogen for Stock and Contingent Value Rights

Acquisition Provides Ligand a Fully Funded Partnership, Research Assets and Cash   SAN DIEGO & BRANFORD, Conn.--(BUSINESS WIRE)--Aug 24, 2009 - Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN)...

Cambrex Receives FDA Warning Letter

EAST RUTHERFORD, N.J., Aug. 24 /PRNewswire-FirstCall/ -- Cambrex Corporation (the "Company") announced that it has received a warning letter from the U.S. Food and Drug Administration ("FDA") relating to an inspection of the Company's generic...

MediciNova and Avigen Enter Into Definitive Agreement for Business Combination

MediciNova and Avigen Enter Into Definitive Agreement for Business Combination SAN DIEGO and ALAMEDA, Calif., Aug. 21, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market...

Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy

 DES PLAINES, Ill. and NEW YORK, Aug. 27 /PRNewswire-FirstCall/ -- Abbott announced today that it has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors...

Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement

Detailed Notice to Shareholders Available on Bristol-Myers Squibb Website NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the United States District Court for the Southern District of New York has granted...

Pfizer and Astellas Announce Co-promotion Agreement for Caduet Combination Tablets

TOKYO, August 26, 2009 – Pfizer Japan Inc. (“Pfizer”) and Astellas Pharma Inc. (“Astellas”) today announced that the companies have reached a co-promotion agreement for a combination drug of hypertension treatment...

WPP Interim Results 2009

Billings up over 11% at £18.742 billion Revenue up over 28% to £4.289 billion Like-for-like revenue down over 8% Headline operating profit down over 24% to £342 million Headline profit before tax down over 35% to...

Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research

Privacy-enhanced search technology addresses privacy concerns to increase patient participation NEW YORK--(BUSINESS WIRE)--Aug 19, 2009 - Recognizing that patient participation in clinical trials is the key to progress in medical research, Pfizer...

Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform

CAMBRIDGE, Mass., Aug 24 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical company, announces today that it has entered into a research-based collaboration with Santaris Pharma A/S, a leading player in RNA-based...

GSK Advisory: Warehouse Theft

 RESEARCH TRIANGLE PARK, N.C., Aug. 24 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) is advising that two lots of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) medication were stolen on August 2 from the...

US Physicians Define Healthcare Reform Platform on Sermo

Seek to Add Real Sources of Spiraling Healthcare Costs to National Debate CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 19, 2009 - Physicians across the nation are speaking out on Sermo (http://www.sermo.com), the world's largest online physician...

FDA Sends Johnson & Johnson and Pedinol Pharmacal Warning Letters

ROCKVILLE, Md., Aug. 27, 2009--The FDA has posted on its web site warning letters it sent to Johnson & Johnson and Pedinol Pharmacal. The agency reviewed a journal advertisement for Johnson & Johnson's Ertaczo Cream. According to...

Study: 3 out of 4 U.S. Nurses Recommend Health Websites to Patients

Manhattan Research Releases New Taking the Pulse® U.S. Nurses Study Giving Insight to How Nurses Use Technology â€" Webinar August 26 NEW YORK, August 24, 2009 â€" Approximately three out of four U.S. nurses recommend health websites to...